These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29489588)

  • 61. Tat-NOL3 protects against hippocampal neuronal cell death induced by oxidative stress through the regulation of apoptotic pathways.
    Sohn EJ; Shin MJ; Eum WS; Kim DW; Yong JI; Ryu EJ; Park JH; Cho SB; Cha HJ; Kim SJ; Yeo HJ; Yeo EJ; Choi YJ; Im SK; Kweon HY; Kim DS; Yu YH; Cho SW; Park M; Park J; Cho YJ; Choi SY
    Int J Mol Med; 2016 Jul; 38(1):225-35. PubMed ID: 27221790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease.
    Mikhaylova ER; Lazarev VF; Nikotina AD; Margulis BA; Guzhova IV
    J Neurochem; 2016 Mar; 136(5):1052-63. PubMed ID: 26662373
    [TBL] [Abstract][Full Text] [Related]  

  • 63. AMPA receptor desensitization is the determinant of AMPA receptor mediated excitotoxicity in purified retinal ganglion cells.
    Park YH; Mueller BH; McGrady NR; Ma HY; Yorio T
    Exp Eye Res; 2015 Mar; 132():136-50. PubMed ID: 25643624
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade.
    Wang D; Li Z; Zhang Y; Wang G; Wei M; Hu Y; Ma S; Jiang Y; Che N; Wang X; Yao J; Yin J
    Epilepsia; 2016 May; 57(5):706-16. PubMed ID: 26945677
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers.
    Brandt C; Töllner K; Klee R; Bröer S; Löscher W
    Neurobiol Dis; 2015 Mar; 75():78-90. PubMed ID: 25549873
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy.
    Zemlyak I; Manley N; Vulih-Shultzman I; Cutler AB; Graber K; Sapolsky RM; Gozes I
    J Neurochem; 2009 Dec; 111(5):1252-63. PubMed ID: 19799711
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuroprotective effects of heptapeptide mystixin.
    Mokrushin AA
    Bull Exp Biol Med; 2013 Nov; 156(1):59-62. PubMed ID: 24319729
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs.
    Tang FR; Bradford HF; Ling EA
    Curr Med Chem; 2009; 16(17):2189-204. PubMed ID: 19519386
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Small molecule anticonvulsant agents with potent in vitro neuroprotection.
    Brenneman DE; Smith GR; Zhang Y; Du Y; Kondaveeti SK; Zdilla MJ; Reitz AB
    J Mol Neurosci; 2012 Jun; 47(2):368-79. PubMed ID: 22535312
    [TBL] [Abstract][Full Text] [Related]  

  • 70. GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation.
    Sen N; Hara MR; Ahmad AS; Cascio MB; Kamiya A; Ehmsen JT; Agrawal N; Hester L; Doré S; Snyder SH; Sawa A
    Neuron; 2009 Jul; 63(1):81-91. PubMed ID: 19607794
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke.
    Lu H; Chen S; Nie Q; Xue Q; Fan H; Wang Y; Fan S; Zhu J; Shen H; Li H; Fang Q; Ni J; Chen G
    Cell Rep; 2023 Mar; 42(3):112233. PubMed ID: 36892998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiepileptic drugs in neuroprotection.
    Pitkänen A; Kubova H
    Expert Opin Pharmacother; 2004 Apr; 5(4):777-98. PubMed ID: 15102563
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Olfactomedin-3 Enhances Seizure Activity by Interacting With AMPA Receptors in Epilepsy Models.
    Tang S; Wang T; Zhang X; Guo Y; Xu P; Zeng J; Luo Z; Li D; Zheng Y; Luo Y; Yu C; Xu Z
    Front Cell Dev Biol; 2020; 8():722. PubMed ID: 32850838
    [No Abstract]   [Full Text] [Related]  

  • 74. Investigating the Effects of Perampanel on Autophagy-mediated Regulation of GluA2 and PSD95 in Epilepsy.
    Li D; Sun N; Guo Y; Huang S; Yin C; Xiao Y; Ma W
    Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38602656
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New in vitro phenotypic assay for epilepsy: fluorescent measurement of synchronized neuronal calcium oscillations.
    Pacico N; Mingorance-Le Meur A
    PLoS One; 2014; 9(1):e84755. PubMed ID: 24416277
    [TBL] [Abstract][Full Text] [Related]  

  • 76. GluA2 modulator targets excitotoxicity in MS.
    Wood H
    Nat Rev Neurol; 2024 Feb; 20(2):63. PubMed ID: 38167675
    [No Abstract]   [Full Text] [Related]  

  • 77. Molecular Mechanism of Tetramethylpyrazine Ameliorating Neuroexcitotoxicity through Activating the PKA/CREB Signaling Pathway.
    Tong H; Wang K; Wang X; Lu T
    Biomed Res Int; 2022; 2022():2812839. PubMed ID: 35097116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target.
    Lazarev VF; Guzhova IV; Margulis BA
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32370188
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct Interaction of PP2A Phosphatase with GABA
    Li X; Terunuma M; Deeb TG; Wiseman S; Pangalos MN; Nairn AC; Moss SJ; Slesinger PA
    J Neurosci; 2020 Apr; 40(14):2808-2816. PubMed ID: 32111696
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Disruption of the GluA2/GAPDH complex using TAT-GluA2NT1-3-2 peptide protects against AMPAR-mediated excitotoxicity after epilepsy.
    Zhang J; Qiao N; Ding X; Wang J
    Neuroreport; 2018 Mar; 29(5):432-439. PubMed ID: 29489588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.